The global synthetic small molecule APIs market to reach $211.21 bn by 2029 at 6.3% CAGR, driven by rising demand for cost-effective generic drugs.
Read More
The global sterile injectables CDMO market to reach $9.89 bn by 2029 at 10.4% CAGR, driven by rising demand for biologics and biosimilars.
Read More
The global sterile injectables CDMO market to reach $9.89 bn by 2029 at 10.4% CAGR, driven by rising demand for biologics and biosimilars.
Read More
The global specialty pharmaceuticals market to reach $861.18 bn by 2029 at 9.7% CAGR, driven by rising chronic diseases due to aging populations.
Read More
Skin health supplements and treatment market to reach $8.73 bn by 2029 at 8.3% CAGR, driven by increasing prevalence of skin disorders.
Read More
Sexually transmitted disease self-testing market to reach $2.21 bn by 2029 at 9.8% CAGR, driven by the rising incidence of syphilis & demand for private testing.
Read More
The global Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists market size is expected to reach $2.20 billion by 2029 at 8.5% CAGR, driven by the increasing prevalence of hormone-related disorders.
Read More
The global Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs market size is expected to reach $2.49 billion by 2029 at 9.5% CAGR, driven by increasing prevalence of ovarian and prostate cancers.
Read More
Global Generic Pharmaceuticals Contract Manufacturing Market Overview: Trends Shaping Growth to 2029
The generic pharmaceuticals contract manufacturing market will reach $87.59B by 2029 at 7.0% CAGR, driven by specialty generics, government support, automation, advanced quality control, and scalable production.
Read More
The gene-editing transfection chemicals market will grow to $1.45B by 2029 at 7.8% CAGR, fueled by gene editing in therapies, biotech investments, non-viral delivery, and nanotech integration.
Read More